Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Journal of Dermatological Science|November 5, 2002
Neuromediators--a crucial component of the skin immune systemThomas A LugerJournal of the American Academy of Dermatology|April 17, 2007
Lichen planus responding to efalizumabMarkus Böhm, Thomas A LugerCurrent Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseasesAnita Rütter, Thomas A LugerExperimental Dermatology|October 28, 2004
Melanocortins in fibroblast biology--current update and future perspective for dermatologyMarkus Böhm, Thomas A LugerClinical and Experimental Rheumatology|October 17, 2015
The skin in psoriasis: assessment and challengesVinzenz Oji, Thomas A LugerHandbook of Experimental Pharmacology|April 12, 2015
NK-1 Antagonists and ItchSonja Ständer, Thomas A LugerAmerican Journal of Clinical Dermatology|June 10, 2004
Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current viewAnita Ruetter, Thomas A LugerActa Dermatovenerologica Croatica : ADC|January 22, 2011
Itch in atopic dermatitis - pathophysiology and treatmentSonja Ständer, Thomas A LugerAnnals of the Rheumatic Diseases|November 21, 2007
alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugsThomas A Luger, Thomas BrzoskaExperimental Dermatology|October 28, 2004
Neutral endopeptidase and angiotensin-converting enzyme -- key enzymes terminating the action of neuroendocrine mediatorsThomas E Scholzen, Thomas A LugerPageof 14